SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-010876
Filing Date
2024-04-16
Accepted
2024-04-16 16:34:41
Documents
1
Period of Report
2024-04-15

Document Format Files

Seq Description Document Type Size
1 form3-04162024_080435.html 3  
1 form3-04162024_080435.xml 3 1719
  Complete submission text file 0001415889-24-010876.txt   3222
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address
San Martin Javier (Reporting) CIK: 0001794629 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39503 | Film No.: 24848244